Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
Product: Cosopt Preservative Free
Active Ingredients: Dorzolamide hydrochloride 22.26mg/mL equivalent to Dorzolamide 20mg/mL
Timolol maleate 6.83mg/mL equivalent to Timolol 5mg/mL
Dosage Form: Eye drops, solution
New Zealand Sponsor: Merck Sharp & Dohme (New Zealand) Limited
Manufacturer: Merck Sharp & Dohme - Chibret, Clermont-Ferrand, France
Dated this 2nd day of August 2013.
DR STEWART JESSAMINE, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).